 |
PDBsum entry 5h6r
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase/transcription/inhibitor
|
PDB id
|
|
|
|
5h6r
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
662 a.a.
|
 |
|
|
|
|
|
|
|
132 a.a.
|
 |
|
|
|
|
|
|
|
14 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase/transcription/inhibitor
|
 |
|
Title:
|
 |
Crystal structure of lsd1-corest in complex with peptide 13
|
|
Structure:
|
 |
Lysine-specific histone demethylase 1a. Chain: a. Fragment: unp residues 172-833. Synonym: braf35-hdac complex protein bhc110,flavin-containing amine oxidase domain-containing protein 2. Engineered: yes. Rest corepressor 1. Chain: b. Fragment: unp residues 308-440.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: kdm1a, aof2, kdm1, kiaa0601, lsd1. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: rcor1, kiaa0071, rcor. Synthetic: yes. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.217
|
R-free:
|
0.231
|
|
|
Authors:
|
 |
M.Kkuchi,Y.Amano,S.Sato,S.Yokoyama,N.Umezawa,T.Higuchi,T.Umehara
|
|
Key ref:
|
 |
Y.Amano
et al.
(2017).
Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.
Bioorg Med Chem Lett,
25,
2617-2624.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Nov-16
|
Release date:
|
12-Apr-17
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O60341
(KDM1A_HUMAN) -
Lysine-specific histone demethylase 1A from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
852 a.a.
662 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.1.14.99.66
- [histone-H3]-N(6),N(6)-dimethyl-L-lysine(4) FAD-dependent demethylase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
N6,N6-dimethyl-L-lysyl4-[histone H3] + 2 A + 2 H2O = L-lysyl4- [histone H3] + 2 formaldehyde + 2 AH2
|
 |
 |
 |
 |
 |
N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3]
|
+
|
2
×
A
|
+
|
2
×
H2O
|
=
|
L-lysyl(4)- [histone H3]
|
+
|
2
×
formaldehyde
|
+
|
2
×
AH2
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
25:2617-2624
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.
|
|
Y.Amano,
M.Kikuchi,
S.Sato,
S.Yokoyama,
T.Umehara,
N.Umezawa,
T.Higuchi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Lysine-specific demethylase 1 (LSD1/KDM1A) is a flavoenzyme demethylase, which
removes mono- and dimethyl groups from histone H3 Lys4 (H3K4) or Lys9 (H3K9) in
complexes with several nuclear proteins. Since LSD1 is implicated in the
tumorigenesis and progression of various cancers, LSD1-specific inhibitors are
considered as potential anti-cancer agents. A modified H3 peptide with
substitution of Lys4 to Met [H3K4M] is already known to be a potent competitive
inhibitor of LSD1. In this study, we synthesized a series of H3K4M peptide
derivatives and evaluated their LSD1-inhibitory activities in vitro. We found
that substitutions of the N-terminal amino acid with amino acids having a larger
side chain were generally not tolerated, but substitution of Ala1 to Ser
unexpectedly resulted in more potent inhibitory activity toward LSD1. X-ray
crystallographic analysis of H3K4M derivatives bound to the LSD1·CoREST complex
revealed the presence of additional hydrogen bonding between the N-terminal Ser
residue of the H3 peptide derivative and LSD1. The present structural and
biochemical findings will be helpful for obtaining more potent peptidic
inhibitors of LSD1.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |